Skip to main content
PROVEXIS PLC logo

PROVEXIS PLC — Investor Relations & Filings

Ticker · PXS ISIN · GB00B0923P27 LEI · 21380042E3Y3N9VZ6N48 IL Professional, scientific and technical activities
Filings indexed 185 across all filing types
Latest filing 2026-05-20 Major Shareholding Noti…
Country GB United Kingdom
Listing IL PXS

About PROVEXIS PLC

https://www.provexis.org/

Provexis PLC is a life sciences company that develops, licenses, and commercializes functional ingredients for the global food, beverage, and dietary supplement markets. The company's principal technology is Fruitflow®, a patented, scientifically-proven bioactive ingredient derived from tomatoes. Fruitflow® is designed to support cardiovascular health by helping to maintain normal blood platelet aggregation, which contributes to healthy blood flow. Provexis licenses its technology to business partners for inclusion in their consumer products.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 94% confidence The document is a TR-1 form giving details of a change in a significant shareholding (notification of major holdings under the Transparency Directive), clearly a major shareholding notification. It is not an AGM, report announcement, or financial statement but a regulatory notice of crossing a voting‐rights threshold. This matches the “Major Shareholding Notification” category.
2026-05-20 English
Half-year Financial Report
Interim / Quarterly Report Classification · 100% confidence The document is titled 'UNAUDITED INTERIM RESULTS FOR SIX MONTHS TO 30 SEPTEMBER 2025' and contains detailed financial highlights, operational updates, and management commentary regarding the company's performance for the interim period. It is a comprehensive report rather than a short announcement, fitting the definition of an Interim/Quarterly Report. H1 2025
2025-12-31 English
Result of AGM
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement from Provexis plc regarding the 'Result of AGM' (Annual General Meeting). It explicitly lists the resolutions passed and provides a detailed table of proxy votes (votes for, against, and withheld). This fits the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2025-11-21 English
Final Results
Earnings Release Classification · 100% confidence The document is titled 'PRELIMINARY RESULTS for the YEAR ended 31 MARCH 2025' and is issued by Provexis PLC. It contains key financial highlights, revenue figures, operating loss, and a Chairman and CEO's statement detailing business performance. While it mentions that the full annual report will be available later, this document itself provides the initial announcement of the audited preliminary financial results for the fiscal year. According to the filing definitions, an initial announcement of periodical financial results is classified as an Earnings Release (ER). FY 2025
2025-10-30 English
Delay in publication of annual accounts
Report Publication Announcement Classification · 100% confidence The document is an RNS (Regulatory News Service) announcement from Provexis PLC. It serves two primary purposes: it provides a trading update (unaudited financial highlights) and, crucially, announces a delay in the publication of its annual accounts, which triggers a temporary suspension of trading on the AIM exchange. While it contains some financial data, it is not the Annual Report itself (which is delayed), nor is it a standard earnings release, but rather a regulatory notice regarding reporting status and trading suspension. Therefore, it fits best under the 'Regulatory Filings' category as a catch-all for such corporate announcements.
2025-09-30 English
Grant of Options and Warrants
Director's Dealing Classification · 99% confidence The document is a formal announcement dated January 7, 2025, originating from Provexis PLC, distributed via RNS (RNS Number: 4486S). The content explicitly details the 'Grant of Options and Warrants' to a director (CEO Ian Ford) and consultants. It includes specific details about the number of options/warrants, exercise prices, and the resulting shareholding percentages. Crucially, it contains a section titled 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them are set out below pursuant to the EU Market Abuse regulation,' which is characteristic of insider transaction reporting. This type of filing, reporting personal share transactions by directors, aligns directly with the definition of Director's Dealing (DIRS). Although it is distributed via RNS, the specific content dictates the classification over the general regulatory fallback.
2025-01-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.